Significant Contract Modifications ($10M+) — July 20, 2026

Leidos Biomedical Research received a $4.81 billion modification from HHS, signaling sustained demand for its biomedical research services and a strong competitive position in the civilian health sector.

Cardinal Intellectual Property's $192 million firm-fixed-price contract with the USPTO provides 13-year revenue visibility, but zero outlayed funds to date create a catalyst to monitor for activation.

OptumServe's $190 million VA contract is 92.4% executed, with no option periods remaining, exposing UnitedHealth Group to potential revenue loss if the recompetition for Region 2 disability exams is not won.

Cardinal Intellectual Property's $192 million USPTO contract has zero outlayed funds, indicating potential delays in contract activation or revenue recognition, which could impact cash flow.

OptumServe's $190 million VA contract is fully executed with no options, exposing UnitedHealth Group to recompetition risk for the Southeast region disability exam contract.

All three contracts are civilian, and the ongoing Continuing Resolution (CR) could delay new obligations or modifications, particularly for the HHS and USPTO contracts.

Leidos Biomedical Research's $4.81B HHS contract modification suggests potential for further expansion in biomedical research services, a growing civilian sector tied to public health priorities.

Cardinal Intellectual Property's 13-year USPTO contract provides a stable revenue base, but the zero outlayed funds create an opportunity for investors if the contract activates and generates predictable cash flows.

The $4.81B HHS award to Leidos Biomedical Research and the $190M VA contract to OptumServe highlight sustained government investment in civilian health services, particularly biomedical research and veteran disability exams.

Cardinal Intellectual Property's 13-year USPTO contract demonstrates the government's willingness to enter long-term agreements for specialized IP services, providing revenue visibility but requiring careful monitoring of execution.

{"entity"=>"Leidos Holdings", "reason"=>"The $4.81B HHS contract modification is a major revenue driver, but the company's overall government services portfolio should be monitored for defense exposure and CR impacts.", "trigger"=>"HHS budget appropriations for FY2027, option exercise announcements"}

{"entity"=>"UnitedHealth Group (OptumServe)", "reason"=>"The $190M VA contract is fully executed, and the company faces recompetition risk for the Southeast region disability exam contract.", "trigger"=>"VA solicitation for Region 2 disability examinations, competitor awards"}

{"entity"=>"Cardinal Intellectual Property Inc.", "reason"=>"The $192M USPTO contract has zero outlayed funds, making it a high-risk, high-reward watch item for revenue recognition.", "trigger"=>"First outlay of funds from USPTO, quarterly USASpending updates"}